Literature DB >> 3681336

Sensory involvement in distal myopathy (Welander).

K Borg1, J Borg, U Lindblom.   

Abstract

Eleven patients with Welander distal myopathy were subjected to detailed sensory testing including measurements of perception thresholds for vibration and temperature in both hands and feet. The threshold values were compared with normal, age-corrected values and also with data from an age-matched control group consisting of patients with antecedent poliomyelitis with the same degree of paresis. The screening examination indicated impaired thermal sensibility in all 11 patients and impairment for at least one other sensory modality in 9 patients. In comparison with age-corrected normal values, the measured warm-cold difference limen was abnormal in the feet of 9 patients and the vibratory threshold at least at one test point in 6 patients. When compared with the data from the paretic controls, the thermal abnormality was significant with regard to warm and cold thresholds, the warm-cold difference limen and the heat pain threshold. The vibration threshold abnormality was significant in the feet. It is concluded that sensibility impairment is present in Welander's myopathy indicating a peripheral sensory neuropathy involving both unmyelinated (C-fibers) and myelinated fibers.

Entities:  

Mesh:

Year:  1987        PMID: 3681336     DOI: 10.1016/0022-510x(87)90166-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Autosomal recessive distal muscular dystrophy.

Authors:  C Scoppetta; B Mercuri; R Di Lello; V S Tolli; G F Mennuni; M L Vaccario
Journal:  Ital J Neurol Sci       Date:  1997-10

2.  Welander's distal myopathy: clinical, neurophysiological and muscle biopsy observations in young and middle aged adults with early symptoms.

Authors:  K Borg; G Ahlberg; J Borg; L Edström
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

Review 3.  Distal myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2014-05-15       Impact factor: 3.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.